| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 08/11/2004 | CN1520303A Turnor therapy with alphavirus-based and high affinity laminin receptor-targeted vectors |
| 08/11/2004 | CN1520300A Dihydro-triterpenes in treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain |
| 08/11/2004 | CN1520299A Use of compounds with combined NEP/MP-inbihitory activity in prepan. of medicaments |
| 08/11/2004 | CN1520298A Pyrazolopyrimidines as therapeutic agents |
| 08/11/2004 | CN1520294A Crystalline anticholinergic, method for its prodn., and use thereof in prdon of drug |
| 08/11/2004 | CN1520292A Medicinal compsns. |
| 08/11/2004 | CN1520291A Fumaric acid derivatives as NF-Kappab inhibitors |
| 08/11/2004 | CN1520290A Carbocyclic hydrorazino inhibitors of copper-containing amine oxidases |
| 08/11/2004 | CN1520285A Tablet comprising cetirizine and pseudoephedrine |
| 08/11/2004 | CN1520283A Control of compactability through crystallization |
| 08/11/2004 | CN1519239A Ramification of a compound of medication as well as preparation method and application |
| 08/11/2004 | CN1519012A Soft capsule of dahurian rhododendron leaf and preparation method |
| 08/11/2004 | CN1161614C Corticotropin releasing factor receptor-1 deficient mice, and method of dertermination agonist agent and antagonist |
| 08/11/2004 | CN1161371C Purification of alpha-1 proteinase inhibitor using novel chromatographic separation conditions |
| 08/11/2004 | CN1161140C Medicine for preventing and treating coronary heart disease and angina pectoris and its prepn and other use |
| 08/11/2004 | CN1161131C Process for preparing antitussive mixture |
| 08/11/2004 | CN1161118C Use of 5HT3 receptor antagouists for the treatment of chronic fatigue syndrome |
| 08/11/2004 | CN1161114C Usage of compound in pharmaceutic mfg. for treating sleep apnoea |
| 08/11/2004 | CN1161112C Pharmaceutical capsule compositions containing loratadine and pseudoephedrine |
| 08/11/2004 | CN1161110C Oral delayed immediate release formulation and method of preparation therefor |
| 08/11/2004 | CN1161104C Pharmaceutical formulations for aerosols with two or more active substances |
| 08/10/2004 | US6774217 Use of fragile histidine triad gene (fhit) genes and their encoded proteins as diagnostic and therapeutic reagents for the detection and treatment of disease states associated with cell overproliferation |
| 08/10/2004 | US6774136 Substituted 1 and 2 naphthol mannich bases |
| 08/10/2004 | US6774127 Pyrazole and pyrazoline substituted compounds |
| 08/10/2004 | US6774121 Phospholipid prodrugs of anti-proliferative drugs |
| 08/10/2004 | US6773912 Lantibiotic |
| 08/10/2004 | US6773728 Herbal composition of blend of active components prepared from murrya koenigii and piper betle useful for blocking of 5 lipoxygenase activity leading to the inhibition of leukotriene synthesis, suppression of interleukin-4 production, and enhancement of gamma interferon release |
| 08/10/2004 | CA2187024C Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them |
| 08/05/2004 | WO2004065365A1 8-azaprostaglandin derivatives and medicinal uses thereof |
| 08/05/2004 | WO2004064867A1 Compositions for prevention and treatment of cold and influenza-like symptoms comprising select mucoadhesive polymers |
| 08/05/2004 | WO2004064860A1 Use of tff2, or agents inducing tff2, in the therapy of allergies |
| 08/05/2004 | WO2004064848A1 Uses of naringenin, naringin and salts thereof as expectorants in the treatment of cough, and compositions thereof |
| 08/05/2004 | WO2004064823A1 Ceramide derivatives for the treatment of inflammation |
| 08/05/2004 | WO2004064742A2 Methods and compositions for p2x receptor calcium entry channels and other calcium entry mechanisms |
| 08/05/2004 | WO2004064716A2 Eicosapentaenoic acid and docosapentaenoic acid for treating inflammatory disorders |
| 08/05/2004 | WO2004064708A2 Solution for nostril wash |
| 08/05/2004 | WO2004029192A3 Producing method of tien hsien liquid |
| 08/05/2004 | WO2004022716A9 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 08/05/2004 | WO2004010974A3 Gelatin capsule exhibiting reduced cross-linking |
| 08/05/2004 | WO2004010973A3 Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage |
| 08/05/2004 | WO2003103590A3 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents |
| 08/05/2004 | WO2003086288A3 Bicyclic amides |
| 08/05/2004 | WO2003042359A3 Histamine receptor h3 polynucleotides |
| 08/05/2004 | US20040152906 Sulfonamides |
| 08/05/2004 | US20040152893 Sulfonamides |
| 08/05/2004 | US20040152891 Sulfonamides |
| 08/05/2004 | US20040152785 Antiarthritic agents; bone disorders; oral diseases; nephritis; atherosclerosis; respiratory system disorders; cirrhosis; vision defects; anticancer agents; autoimmune diseases |
| 08/05/2004 | US20040152779 Bicyclic amino acids as pharmaceutical agents |
| 08/05/2004 | US20040152775 Using a compound containing a amine and a sulfinate group; gastrointestinal disorders |
| 08/05/2004 | US20040152754 Cyclic AMP-specific phosphodiesterase inhibitors |
| 08/05/2004 | US20040152753 Methods of use for novel sulfur containing organic nitrate compounds |
| 08/05/2004 | US20040152738 Wound healing agents; antiarthritic agents; osteoporosis; congestive heart failure; antiulcer agents; Alzheimer's disease; anticholesterol agents; antiarthritic agents |
| 08/05/2004 | US20040152731 4-(Phenyl-(piperidin-4-yl)-amino)-benzamide derivaties and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 08/05/2004 | US20040152730 Novel compounds |
| 08/05/2004 | US20040152726 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 08/05/2004 | US20040152725 Anticancer agents using a compound containing urea group |
| 08/05/2004 | US20040152723 Pharmaceutical compositions and methods for use |
| 08/05/2004 | US20040152707 Analgesics; anxiolytic agents; antihistamines; antitussive agents; antidepressants; alcoholism |
| 08/05/2004 | US20040152705 Pyrazino 1',2':1,6 pyrido 3,4-b indole1,4-dione derivatives |
| 08/05/2004 | US20040152692 Pyrrolidine sulfonamides |
| 08/05/2004 | US20040152680 Treating autoimmune diseases, skin disorders, malignancies |
| 08/05/2004 | US20040152679 (20S)-1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses |
| 08/05/2004 | US20040152678 Administering 20S)-1 alpha -hydroxy-2 alpha -methyl-19-nor-vitamin D3 for therapy of psoriasis |
| 08/05/2004 | US20040152677 (20S)-1alpha-hydroxy-2alpha-methl and 2beta-methyl-19-nor-vitamin D3 and their uses |
| 08/05/2004 | US20040152676 (20S)-1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses |
| 08/05/2004 | US20040152675 (20S)-1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses |
| 08/05/2004 | US20040152653 Administering a pharmacologic complex to the airway epithelium via its luminal surface, wherein the complex comprises a ligand for serpin enzyme complex receptor (SecR) and a pharmacologic agent |
| 08/05/2004 | US20040152163 Comprises nucleotide sequences coding sulfotransferase for identifying modulators and designing drug delivery systems |
| 08/05/2004 | US20040152157 G-protein coupled receptors |
| 08/05/2004 | US20040152156 Nucleotide sequences coding counter-ligands for several receptors expressed on lymphocytes for use in diagnosis and treatment of asthma, allergic or inflammatory disease |
| 08/05/2004 | US20040152078 Genetic engineering |
| 08/05/2004 | US20040149133 Portable oxygen concentrator |
| 08/05/2004 | DE10304374A1 Neue substituierte 2-Aminoimidazole, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament New substituted 2-Aminoimidazole, processes for their preparation, their use as a medicament or diagnostic, and they drug-containing |
| 08/05/2004 | CA2512709A1 Use of tff2, or agents inducing tff2, in the therapy of allergies |
| 08/04/2004 | EP1443041A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, medicinal compositions containing the same, medicinal use thereof and intermediates in the production thereof |
| 08/04/2004 | EP1442114A2 Novel bacterial poultry disease |
| 08/04/2004 | EP1442060A2 A novel g protein-coupled receptor, gave 10 |
| 08/04/2004 | EP1442050A2 Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 08/04/2004 | EP1442042A1 Polycyclic guanine derivative phosphodiesterase v inhibitors |
| 08/04/2004 | EP1442039A1 Pyrimido (4,5-b) indole derivatives |
| 08/04/2004 | EP1442036A2 Heteroaryl derivatives as superior ligands for nociceptin receptor orl-1 |
| 08/04/2004 | EP1442034A1 Benzimidazole derivatives and their use as kdr protein kinase inhibitors |
| 08/04/2004 | EP1442032A1 Heterocyclic retinoid compounds |
| 08/04/2004 | EP1442017A1 Preparation of benzosuberonylpiperidine compounds |
| 08/04/2004 | EP1441785A2 Improved method for generating an aerosol |
| 08/04/2004 | EP1441772A2 Polymer conjugates of protein kinase c inhibitors |
| 08/04/2004 | EP1441762A1 Rsv gene expression vaccine |
| 08/04/2004 | EP1441752A1 Endophilin homologous proteins involved in the regulation of energy homeostasis |
| 08/04/2004 | EP1441738A1 A combination product comprising melagatran and dexamethasone |
| 08/04/2004 | EP1441732A2 Thiazole derivative and pharmaceutical use thereof |
| 08/04/2004 | EP1441730A1 Hydrazono-malonitriles |
| 08/04/2004 | EP1441725A1 Benzimidazoles and analogues and their use as protein kinases inhibitors |
| 08/04/2004 | EP1441723A1 Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension |
| 08/04/2004 | EP1441715A1 Lipoxins and aspirin-triggered lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases |
| 08/04/2004 | EP1441701A1 Montelukast granule formulation |
| 08/04/2004 | EP1441697A2 Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease |
| 08/04/2004 | EP1368027B1 Use of tryptophan derivatives for the specific cytostatic treatment of serotonin-producing tumors |
| 08/04/2004 | EP1289945B1 Aniline disulfide derivatives for treating allergic diseases |
| 08/04/2004 | EP1280806B1 THIENO 2,3-d]PYRIMIDINEDIONES AND THEIR USE AS PHARMACEUTICALS |
| 08/04/2004 | EP1278750B1 Imidazopyrimidine derivatives and triazolopyrimidine derivatives |